Sage Journals: Discover world-class research

Abstract

Background:

The correlation between Alzheimer's disease (AD) and the glucose-triglyceride (TyG) index remains undetermined.

Objective:

This study aimed to investigate the relationship between the TyG index and AD, as well as the relationship between the TyG index and cerebrospinal fluid (CSF) AD biomarkers and cognition.

Methods:

Six hundred twenty-eight non-dementia participants were included. The TyG index, pathological markers, and cognitive measures were studied using multiple linear regression. Also calculated using a multivariate Cox regression model were the hazard ratio (HR) and its 95% confidence interval (CI). Ten thousand bootstrap iterative causal mediation analyses were performed to investigate the potential mediating effect of AD pathology on cognition.

Results:

The TyG index was linked to CSF AD biomarkers (β_Aβ42= 0.880; β_Tau= −0.674; β_pTau= −0.884; β_Aβ42/pTau= 1.764; β_Aβ42/Tau= 1.554; β_pTau/Tau= −0.210) and cognitive measurements (β_MEM= 0.570; β_EF= 0.535; β_ADAS11= −0.789). Mediation analysis revealed that the TyG index may influence cognition via CSF AD biomarkers, including Aβ₄₂, tau, and pTau. Furthermore, each 1-unit increase in TyG index was associated with a 29.5% reduction in the risk of incident AD.

Conclusions:

A delayed rate of cognitive decline and a reduced risk of AD were found to be correlated with higher levels of the TyG index, but this does not mean increasing TyG index levels is beneficial for health. Through AD pathology, the TyG index may influence AD and cognitive changes.

Keywords

alzheimer's disease cognition insulin resistance triglyceride-glucose index

Get full access to this article

View all access options for this article.

References

Tian

Song

Hou

, et al. Association of triglyceride-glucose index with cognitive function and brain atrophy: a population-based study. Am J Geriatr Psychiatry 2024; 32: 151–162.

Pasinetti

Eberstein

. Metabolic syndrome and the role of dietary lifestyles in Alzheimer's disease. J Neurochem 2008; 106: 1503–1514.

Kellar

Craft

. Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol 2020; 19: 758–766.

Craft

. Alzheimer disease: insulin resistance and AD–extending the translational path. Nature Reviews Neurology 2012; 8: 360–362.

Willette

Johnson

Birdsill

, et al. Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement 2015; 11: 504–510.e501.

Willette

Johnson

, et al. Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care 2013; 36: 443–449.

Zhou

Ryan

Tonkin

, et al. Association between triglycerides and risk of dementia in community-dwelling older adults: a prospective cohort study. Neurology 2023; 101: e2288–e2299.

Khan

Sobia

Niazi

, et al. Metabolic clustering of risk factors: evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr 2018; 10: 74.

Simental-Mendía

Guerrero-Romero

. The correct formula for the triglycerides and glucose index. Eur J Pediatr 2020; 179: 1171.

10.

Wang

Zhou

, et al. Independent and joint associations between the triglyceride-glucose index and NT-proBNP with the risk of adverse cardiovascular events in patients with diabetes and acute coronary syndrome: a prospective cohort study. Cardiovasc Diabetol 2023; 22: 149.

11.

Sánchez-García

Rodríguez-Gutiérrez

Mancillas-Adame

, et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol 2020; 2020: 4678526.

12.

Vasques

Novaes

de Oliveira Mda

, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 2011; 93: e98–e100.

13.

DeFronzo

Tobin

Andres

. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–E223.

14.

Sun

Xie

, et al. Association of the triglyceride-glucose index with risk of Alzheimer's disease: a prospective cohort study. Am J Prev Med 2023; 65: 1042–1049.

15.

Hong

Han

Park

. The insulin resistance by triglyceride glucose index and risk for dementia: population-based study. Alzheimers Res Ther 2021; 13: 9.

16.

Tian

Dong

, et al. Triglyceride-glucose index, Alzheimer's disease plasma biomarkers, and dementia in older adults: the MIND-China study. Alzheimers Dement (Amst) 2023; 15: e12426.

17.

Petersen

Aisen

Beckett

, et al. Alzheimer's disease neuroimaging initiative (ADNI): clinical characterization. Neurology 2010; 74: 201–209.

18.

Cui

Song

, et al. Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults. Cardiovasc Diabetol 2024; 23: 185.

19.

Shaw

Vanderstichele

Knapik-Czajka

, et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 2009; 65: 403–413.

20.

2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 2021; 44: S15–s33.

21.

Boizel

Benhamou

Lardy

, et al. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 2000; 23: 1679–1685.

22.

Jack

CR Jr

Bennett

Blennow

, et al. NIA-AA Research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement 2018; 14: 535–562.

23.

Hansson

Zetterberg

Buchhave

, et al. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5: 228–234.

24.

Janelidze

Stomrud

Palmqvist

, et al. Plasma β-amyloid in Alzheimer's disease and vascular disease. Sci Rep 2016; 6: 26801.

25.

Fagan

Mintun

Shah

, et al. Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease. EMBO Mol Med 2009; 1: 371–380.

26.

McKhann

Drachman

Folstein

, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984; 34: 939–944.

27.

Wang

, et al. P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders. Alzheimers Res Ther 2021; 13: 200.

28.

Levey

Bosch

Lewis

, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461–470.

29.

Baron

Kenny

. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986; 51: 1173–1182.

30.

Wang

Ling

, et al. Association between triglyceride glucose index with cognitive impairment and dementia: a meta-analysis. Front Aging Neurosci 2023. 15: 1278730.

31.

Zhang

Chen

Sheng

. Association of triglyceride glucose-body mass index with Alzheimer's disease pathology, cognition and brain structure in non-demented people. Sci Rep 2024; 14: 16097.

32.

Wang

Liu

, et al. Sex differences in the association between the change in triglyceride-glucose index and cognitive decline: a population-based cohort study. J Affect Disord 2022; 316: 42–49.

33.

Santulli

Visco

Varzideh

, et al. Prediabetes increases the risk of frailty in prefrail older adults with hypertension: beneficial effects of metformin. Hypertension 2024; 81: 1637–1643.

34.

Wei

Koya

Reznik

. Insulin resistance exacerbates Alzheimer disease via multiple mechanisms. Front Neurosci 2021; 15: 687157.

35.

Sędzikowska

Szablewski

. Insulin and insulin resistance in Alzheimer's disease. Int J Mol Sci 2021; 22: 9987.

36.

Gentreau

Reynes

Sabatier

, et al. Glucometabolic changes are associated with structural gray matter alterations in prodromal dementia. J Alzheimers Dis 2022; 89: 1293–1302.

37.

Schrijvers

Witteman

Sijbrands

, et al. Insulin metabolism and the risk of Alzheimer disease: the Rotterdam study. Neurology 2010; 75: 1982–1987.

38.

Bernath

Bhattacharyya

Nho

, et al. Serum triglycerides in Alzheimer disease: relation to neuroimaging and CSF biomarkers. Neurology 2020; 94: e2088–e2098.

39.

Freeman

Granholm

. Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet. J Cereb Blood Flow Metab 2012; 32: 643–653.

40.

Nguyen

Killcross

Jenkins

. Obesity and cognitive decline: role of inflammation and vascular changes. Front Neurosci 2014; 8: 375.

41.

Kleinridders

Ferris

Cai

, et al. Insulin action in brain regulates systemic metabolism and brain function. Diabetes 2014; 63: 2232–2243.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.62 MB

The association of the triglyceride-glucose index with Alzheimer's disease and its potential mechanisms

Abstract

Background:

Objective:

Methods:

Results:

Conclusions:

Keywords

Get full access to this article

References

Supplementary Material